British Biotech nears cancer drug deal
Tuesday 07 September 1999
A company source yesterday said a deal was "imminent". Shares in the company closed up 6.25p, or 20 per cent, at 37.25p yesterday following reports at the weekend that a licensing deal would be announced the company's annual meeting, scheduled for 23 September.
However, it now appears a deal is ready to be signed. Possible candidates for the partnership include US groups Merck, Pharmacia & Upjohn, and Eli Lilly.
The partnership agreement is expected to take the form of an upfront licence fee, with regular milestone payments tied to further trials.
The deal follows the publication last month of mixed results for Marimastat, a treatment for gastric cancer, in clinical trails. While the drug failed in its primary goal of prolonging overall survival significantly at a pre-determined end-point, the company claims it was successful if the data from nine patients, who violated the trial's protocol, were discounted.
The drug showed also significant effects in arresting the development of tumours, a secondary target of the study, prompting the company to approach regulators for possible marketing approval of the drug.
Even if Marimastat becomes a commercial product, it may not lead to a revival in the fortunes of British Biotech, whose shares crashed in 1997 after one its directors took issue publicly with its statements about drugs in development. The company's management has since been overhauled.
While there is no available treatment for gastric cancer after chemotherapy or operation, some observers doubt whether doctors would allocate resources to a treatment which adds perhaps only days to a patient's life.
- 1 East 17 bandmember Brian Harvey in 'very desperate situation’
- 2 Germanwings plane crash: Video shows co-pilot Andreas Lubitz learning to fly as a teenager
- 3 Vladimir Putin says Russia will fight for the right of Palestinians to their own state
- 4 Germanwings crash: Captain of doomed plane was only 'on board because he changed job to spend more time with his children'
- 5 WrestleMania 31 results: Seth Rollins stuns WWE as he cashes in Money in the Bank contract to claim title from Brock Lesnar
East 17 bandmember Brian Harvey in 'very desperate situation’
Vladimir Putin says Russia will fight for the right of Palestinians to their own state
Ohio Democrat Teresa Fedor speaks out during abortion debate to reveal she has been raped – and is interrupted by laughter from Republicans
Children take eight Isis captives to be beheaded in latest propaganda video
Jeremy Clarkson 'could be given minder' ahead of a potential Top Gear return
Ukip supporters are 55 or older, white and socially conservative, finds British Social Attitudes Report
JK Rowling responds to fan tweeting she 'can't see' Dumbledore being gay
Street preacher quoting from the Bible fined for calling homosexuality an 'abomination'
Jeremy Clarkson sacked live: Alan Yentob 'wouldn't rule out' ex Top Gear host's BBC return
Woman filmed launching racist tirade against men on the Tube for speaking in 'own lingo'
The West has it totally wrong on Lee Kuan Yew
iJobs Money & Business
£25000 - £30000 per annum + benefits: Ashdown Group: A global leader operating...
£32000 - £38000 per annum + benefits: Ashdown Group: A highly successful, inte...
£20000 - £35000 per annum: Recruitment Genius: This multi-award winning foreig...
Negotiable: Recruitment Genius: To provide a prompt, friendly and efficient se...